Update on BMS Nivolumab Phase III Trial

› Forums › General Melanoma Community › Update on BMS Nivolumab Phase III Trial

  • This topic is empty.
  • Post
    • June 25, 2014 at 1:40 am
    RJoeyB
    Participant
      FYI, I posted this over at MIF, too, figured it was worth cross-posting here.
       
      This is good to see, BMS is seeing such superior results for nivo vs. dacarbazine (no kidding, right?) in the Phase III trial that they are closing the trial and allowing the dacarbazine patients to cross-over to the nivo arm.
       
       
      Joe
       
       
    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics